TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Other Current Assets
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Other Current Assets of $158.70 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$24.27K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for the quarter ending 2026-03-31 was $182.97K, a 509.94% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$124.45K, a 123.28% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$222.66K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for fiscal 2025 was -$457.52K, a 198.41% decline from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for fiscal 2024 was $464.94K, a 23205.16% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other current assets for fiscal 2023 was $2.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$24.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $158.70K 10-Q · filed 2026-08-14 | $34.26K derived: sum of 3 quarters · filed 2026-08-14 | -$188.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $182.97K 10-Q · filed 2026-05-15 | $58.52K derived: sum of 2 quarters · filed 2026-05-15 | -$164.13K derived: sum of 3 quarters · filed 2026-05-15 | -$304.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$124.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$347.11K derived: sum of 2 quarters · filed 2026-03-31 | -$487.52K derived: sum of 3 quarters · filed 2026-08-14 | -$457.52K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$222.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$363.07K derived: sum of 2 quarters · filed 2026-08-14 | -$333.08K 10-Q · filed 2025-11-14 | $201.56K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$140.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$110.42K 10-Q · filed 2026-08-14 | $424.22K derived: sum of 3 quarters · filed 2026-08-14 | $388.22K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-15 | $564.64K derived: sum of 2 quarters · filed 2026-05-15 | $528.64K derived: sum of 3 quarters · filed 2026-05-15 | $493.53K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $534.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $498.64K derived: sum of 2 quarters · filed 2026-03-31 | $463.53K derived: sum of 3 quarters · filed 2026-03-31 | $464.94K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$71.11K derived: sum of 2 quarters · filed 2025-11-14 | -$69.70K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$35.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$33.70K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.41K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $2.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |